Literature DB >> 1847579

Small cell carcinomas of the large intestine.

A B Burke1, K M Shekitka, L H Sobin.   

Abstract

The authors studied the clinical and pathologic features of 38 small cell carcinomas of the large intestine. Most were located in the right colon. Overlying adenomas were present in 45% and squamous differentiation in 21% of tumors. Endocrine differentiation was present in all tumors by at least one method; neuron-specific enolase, dense-core granules, and synaptophysin were present in most cases. Seventy-one percent of tumors metastasized to the liver; 64% of patients were dead at five months follow-up. Twenty-one poorly differentiated adenocarcinomas and undifferentiated carcinomas of the large intestine accessioned during the same period showed less endocrine (7 of 21) and squamous differentiation (1 of 15) and fewer liver metastases (4 of 15) than did small cell carcinomas. Among all 59 tumors studied, small cell histologic characteristics correlated better with liver involvement than did endocrine markers or other histologic features. Small cell carcinomas of the large intestine are aggressive tumors with a propensity for early liver involvement. Although there is a spectrum of squamous, endocrine, and glandular features in large bowel tumors of low degrees of differentiation, the identification of a small cell component appears to be most clinically relevant.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847579     DOI: 10.1093/ajcp/95.3.315

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  14 in total

1.  A case of primary colonic small-cell carcinoma arising in a patient with long-standing ulcerative colitis.

Authors:  Renée M Marchioni Beery; Thomas J Devers; Jessica M Clement
Journal:  Gastrointest Cancer Res       Date:  2014-05

Review 2.  High-grade neuroendocrine carcinoma of the colon, long-term survival in advanced disease.

Authors:  Derek G Power; Timothy R Asmis; Laura H Tang; Karen Brown; Nancy E Kemeny
Journal:  Med Oncol       Date:  2010-09-14       Impact factor: 3.064

3.  A case of strongly suspected Lynch syndrome with colorectal neuroendocrine carcinoma.

Authors:  Naoya Kobayashi; Hiroshi Yoshida; Shinya Kawaguchi; Satoru Shiraso; Noriko Nemoto; Nanako Fujikawa; Yoichi Haji; Emiko Kono; Shoji Kokubo; Kazuhiko Tsukuda; Shigeyuki Asano; Fumiaki Shinya
Journal:  Surg Case Rep       Date:  2022-06-17

4.  Squamous cell carcinoma of the splenic flexure of the colon: report of a case.

Authors:  J Yoshida; H Tohma; T Nagata; Y Okuzono; M Takahashi
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

5.  A case report of endocrine cell carcinoma in the sigmoid colon with inferior mesenteric vein tumor embolism.

Authors:  Yusuke Tanoue; Nobutaka Tanaka; Yoshio Suzuki; Shoujirou Hata; Aya Yokota
Journal:  World J Gastroenterol       Date:  2009-01-14       Impact factor: 5.742

Review 6.  Ectopic ACTH syndrome associated with anorectal carcinoma. Report of a case and review of the literature.

Authors:  R K Sterling
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

Review 7.  Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.

Authors:  Günter Klöppel; Guido Rindi; Martin Anlauf; Aurel Perren; Paul Komminoth
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

8.  Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases.

Authors:  Bruna Estrozi; Carlos E Bacchi
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

9.  Limited stage small cell carcinoma of the gastrointestinal tract: a clinicopathologic and prognostic analysis of 27 cases.

Authors:  Chunyan Peng; Shanshan Shen; Xiaoqi Zhang; Xiaoping Zou
Journal:  Rare Tumors       Date:  2013-05-02

10.  Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases.

Authors:  B Brenner; M A Shah; M Gonen; D S Klimstra; J Shia; D P Kelsen
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.